Filter Results :

Your search for Cancer Drug Market returned 117 reports

Sort by


Immunotherapy Drugs Market by Type of Drugs (Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha), Therapy Area (Cancer, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals), Region (North America, Asia-Pacific) - Global Forecast to 2021

06 Jan 2017  |  Published by:  MarketsandMarkets
The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.  In this report, the immunotherapy drugs market is segmented on the basis of type of drugs, therapy area...

$ 5,650.00

Read More

Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Breast Cancer Report is to understand the market a...

$ 2,000.00

Read More

Cancer Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Cancer Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Cancer Pain Report is to understand the market and p...

$ 2,000.00

Read More

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key o...

$ 2,000.00

Read More

Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Lung Cancer Report is to understand the market and p...

$ 2,000.00

Read More

Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Metastatic Prostate Cancer Report is ...

$ 2,000.00

Read More

Non-Small Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Non-Small Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Non-Small Cell Lung Cancer Report is ...

$ 2,000.00

Read More

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Ovarian Cancer Report is to understand the market...

$ 2,000.00

Read More

Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Prostate Cancer Report is to understand the mark...

$ 2,000.00

Read More

Rectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Rectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Rectal Cancer Report is to understand the market a...

$ 2,000.00

Read More

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Bladder Cancer Report is to understand the market...

$ 2,000.00

Read More

Cervical Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Cervical Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Cervical Cancer Report is to understand the mark...

$ 2,000.00

Read More

Colon Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Colon Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Colon Cancer Report is to understand the market and...

$ 2,000.00

Read More

Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Colorectal Cancer Report is to understand the ...

$ 2,000.00

Read More

Esophageal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jan 2017  |  Published by:  DelveInsight
Esophageal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Esophageal Cancer Report is to understand the ...

$ 2,000.00

Read More
Total 117 records.